https://www.selleckchem.com/pr....oducts/omaveloxolone
Seventeen PLWH with ESRD on HD were included after documented ARV simplification. At 12 months, 12 patients (71%) remained undetectable (HIV VL less then 50 copies/mL) with two additional maintaining viral suppression ( less then 200 copies/mL). One patient remained undetectable at month eight but became non-adherent with viral rebound. Two patients did not complete the 6- and 12-month evaluation after documented nonadherence (N = 1) and an adverse effect (pruritus) (N = 1). At 12 months, virologic suppression and tolerabi
Like
Comment
Share
